Saliva-based Screening Market to Witness Remarkable Surge, Expected to Cross US$ 738.5 Million by 2033 | Persistence Market Research
04. August 2023 09:10 ET
|
Persistence Market Research
New York, Aug. 04, 2023 (GLOBE NEWSWIRE) -- The global saliva-based screening market is estimated to generate US$ 320.6 Million in 2022, with the global market growing at a CAGR of 7.9% to a...
Benasource Selects Acupath Laboratories to Bring COVID-19 Saliva PCR Assay to Independent Pharmacies Across the Country
05. Mai 2021 12:27 ET
|
Acupath
PLAINVIEW, N.Y. , May 05, 2021 (GLOBE NEWSWIRE) -- Acupath Laboratories, Inc., a leading provider of sub-specialized anatomic and molecular pathology services, today announced it will provide...
Acupath Laboratories Announces Expansion of COVID-19 Test Offerings With Introduction of Low-Cost Saliva PCR Assay
13. April 2021 12:15 ET
|
Acupath
PLAINVIEW, N.Y., April 13, 2021 (GLOBE NEWSWIRE) -- Acupath Laboratories, Inc., a leading provider of sub-specialized anatomic and molecular pathology services, today announced the availability of...
Oral Fluid Testing Capabilities Expanded to Identify Pertinent Drug Interactions
09. November 2020 11:00 ET
|
Aegis Sciences Corporation
NASHVILLE, Tenn., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting...
US and Canadian Officials Scramble to Solve Marijuana-Impaired Driving Issue -- CFN Media
17. April 2018 08:00 ET
|
CFN Media
SEATTLE, April 17, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of...
Lifepoint Announces Expanded Navy License for Saliva Diagnostics
29. April 1999 09:58 ET
|
LifePoint, Inc.
ONTARIO, Calif., April 29, 1999 (PRIMEZONE) -- LifePoint, Inc. (OTC BB: LFPT), a developer of rapid, non-invasive testing products using saliva, announced today a modified and enhanced agreement for...